Get the Stockscreener App
86.33
1.12%
0.96
After Hours:
86.33
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $86.33, with a volume of 5.11M.
It is up +1.12% in the last 24 hours and up +1.40% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$85.37
Open:
$85.36
24h Volume:
5.11M
Relative Volume:
0.79
Market Cap:
$69.08B
Revenue:
$20.80B
Net Income/Loss:
$2.22B
P/E Ratio:
33.50
EPS:
2.5772
Net Cash Flow:
$3.77B
1W Performance:
+0.77%
1M Performance:
+1.40%
6M Performance:
+12.25%
1Y Performance:
-4.86%
1-Day Range:
$84.08
$87.33
1-Week Range:
$84.08
$89.34
52-Week Range:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
86.33 | 68.31B | 20.80B | 2.22B | 3.77B | 2.5772 |
PG
Procter Gamble Co
|
144.90 | 333.97B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.42 | 128.22B | 56.67B | 6.96B | 7.39B | 3.1265 |
KVUE
Kenvue Inc
|
17.37 | 32.93B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
97.20 | 31.75B | 16.56B | 1.75B | 1.84B | 6.36 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Mar-31-26 | Downgrade | TD Cowen | Buy → Hold |
| Mar-30-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-13-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-07-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Colgate puts evidence into action at new event - Dentistry.co.uk
Is Colgate Palmolive (CL) Price Still Attractive After Modest Recent Gains? - simplywall.st
Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock? - Barchart.com
Barclays Forecasts Strong Price Appreciation for Colgate-Palmolive (NYSE:CL) Stock - MarketBeat
Every Colgate Smile Has A Story: Celebrating Real People, Real Stories, and Real Impact - PR Newswire
Varma Mutual Pension Insurance Co Boosts Holdings in Colgate-Palmolive Company $CL - MarketBeat
JPMorgan Chase & Co. Issues Positive Forecast for Colgate-Palmolive (NYSE:CL) Stock Price - MarketBeat
CL Reiterated by RBC Capital -- Maintains Price Target at $102 - GuruFocus
Colgate-Palmolive's (CL) "Outperform" Rating Reaffirmed at Royal Bank Of Canada - MarketBeat
UBS raises Colgate-Palmolive stock price target on strong quarter By Investing.com - Investing.com India
UBS raises Colgate-Palmolive stock price target on strong quarter - Investing.com
Did Colgate Really Sell Frozen Lasagna In The '60s? - Yahoo
Colgate-Palmolive Warns Of $300m Cost Hit From Middle East Conflict - ESM Magazine
Colgate Palmolive India debuts real stories platform - Mediabrief.com
CL Q1 Deep Dive: Emerging Markets and Cost Pressures Shape 2026 Outlook - Yahoo Finance UK
Does Colgate-Palmolive’s Q1 2026 Results And New Savings Plan Change The Bull Case For CL? - simplywall.st
Is Colgate-Palmolive a Good Stock to Buy? - HarianBasis.co
PKO Investment Management Joint Stock Co Acquires Shares of 22,740 Colgate-Palmolive Company $CL - MarketBeat
CX Institutional Purchases 15,983 Shares of Colgate-Palmolive Company $CL - MarketBeat
FRANKLIN MUTUAL SHARES VIP FUND's Colgate-Palmolive Co(CL) Holding History - GuruFocus
MSN Money - MSN
US Bancorp DE Decreases Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company (NYSE:CL) Q1 2026 Earnings Call Transcript - Insider Monkey
Colgate-Palmolive Company (NYSE:CL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Colgate-Palmolive Co (CL) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Colgate-Palmolive (CL) One Off Loss Hits Margins And Tests Premium P E Narrative - simplywall.st
Is Colgate-Palmolive (CL) 3.9% Undervalued After Q1 2026? GAAP E - GuruFocus
Colgate-Palmolive stock price forecast: $89.50 resistance as CL jumps 3.54% - Traders Union
Buying pressure lifts Colgate-Palmolive stock higher in today's trading - Traders Union
What's Going On With Colgate-Palmolive Stock Friday?Colgate-Palmolive (NYSE:CL) - Benzinga
Colgate-Palmolive warns of $300M cost hit from Middle East conflict - CTV News
Colgate-Palmolive beats Q1 estimates on strong international demand By Reuters - Investing.com
Colgate-Palmolive beats Q1 estimates on strong international demand - 93.3 The Drive
Colgate Q1 2026 slides: beats forecasts as innovation lifts share - Investing.com
Earnings call transcript: Colgate-Palmolive Q1 2026 beats forecasts, stock rises - Investing.com
Colgate Growth Beats as Global Consumers Offset US Weakness - Bloomberg.com
Colgate-Palmolive (NYSE:CL) Delivers Top-Line Beat as Full-Year Margin Outlook Dulls Q1 EPS Miss - ChartMill
Colgate-Palmolive (NYSE: CL) grows Q1 2026 sales while expanding major productivity program - Stock Titan
Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up - RTTNews
Q1 2026 Colgate-Palmolive Co Earnings Call Transcript - GuruFocus
Colgate-Palmolive Company $CL Stock Holdings Lowered by Savoir Faire Capital Management L.P. - MarketBeat
Colgate-Palmolive (NYSE: CL) lifts Q1 sales and expands savings program - Stock Titan
Colgate-Palmolive Sales Rise on International Growth - WSJ
Colgate-Palmolive tops Q1 expectations after broad-based growth, shares gain - Investing.com
Colgate-Palmolive: Q1 Earnings Snapshot - Barchart.com
Colgate holds 41.1% toothpaste share as quarterly sales climb 8.4% - Stock Titan
Colgate-Palmolive's Q1 net sales above forecast at $5.3B - Breakingthenews.net
State of New Jersey Common Pension Fund D Has $20.19 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Danica Pension Livsforsikringsaktieselskab Decreases Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
If you purchased Tom's toothpaste within the last 6 years, you could be eligible for a payout - MSN
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):